Blogs
From the Proscia blog: With AI-driven pathology rapidly advancing, we launched The 2025 Laboratory Leadership Report to better understand what’s top of mind for today’s pathology leaders—and where they’re headed next. Some findings...
The latest from the Proscia blog: By Coleman Stavish | June 25, 2025 The Spring 2025 DICOM Working Group 26 (WG26) Whole Slide Imaging (WSI) Connectathon brought together key stakeholders shaping the future of digital pathology...
From the Proscia blog: At this year’s Digital Pathology & AI Congress, I had the privilege of leading a pre-conference workshop with what might have seemed like an ambitious goal: help participants build a real AI application in under...
From the blog of Indica Labs: In this interview with Donald Allen of the Life Sciences Product Management team, Indica Labs proves its continuous innovation with the inclusion of a cutting-edge foundation model in HALO...
Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the development and commercialization of advanced diagnostic tools aimed at expanding precision medicine. Leveraging DHR’s newly...
From the Aiosyn Blog IVDR represents a significant overhaul of regulations requiring more rigorous oversight, clinical validation assessed by a Notified Body, and stricter post-market surveillance (PMS). Aiosyn’s AI-powered...
